UnitedHealth Group (NYSE:UNH) updated its FY20 earnings guidance on Monday. The company provided earnings per share guidance of $16.25-16.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $16.43. The company issued revenue guidance of $260-262 billion, compared to the consensus revenue estimate of $261.18 billion.UnitedHealth Group also updated its FY19 guidance to approach $15 EPS.

A number of research analysts have recently issued reports on the company. Citigroup decreased their target price on UnitedHealth Group from $299.00 to $286.00 and set a buy rating on the stock in a research report on Wednesday, October 16th. BMO Capital Markets lowered UnitedHealth Group from an outperform rating to a market perform rating and decreased their target price for the company from $292.00 to $249.00 in a research report on Monday, September 30th. SunTrust Banks reiterated a buy rating and set a $335.00 target price (up previously from $310.00) on shares of UnitedHealth Group in a research report on Monday, November 18th. Morgan Stanley reissued a buy rating and issued a $312.00 price objective (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Finally, Barclays increased their price objective on UnitedHealth Group from $260.00 to $305.00 and gave the company an overweight rating in a research note on Monday. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of Buy and a consensus target price of $289.39.

NYSE UNH traded down $0.21 during mid-day trading on Monday, hitting $279.66. The stock had a trading volume of 2,517,060 shares, compared to its average volume of 4,483,900. The firm’s 50 day moving average is $258.05 and its 200 day moving average is $245.34. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market capitalization of $265.15 billion, a price-to-earnings ratio of 21.71, a PEG ratio of 1.48 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. During the same period in the prior year, the company earned $3.41 EPS. The firm’s revenue was up 6.7% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group will post 14.96 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend is Friday, December 6th. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of $232.76, for a total value of $581,900.00. Following the completion of the sale, the director now directly owns 187,979 shares of the company’s stock, valued at $43,753,992.04. The disclosure for this sale can be found here. Insiders sold a total of 38,577 shares of company stock valued at $9,398,080 over the last ninety days. Corporate insiders own 0.82% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is an economic bubble?

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.